| State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy | 2020/02/01 | English | 446 |
| Microbiota-Brain-Gut Axis and Neurodegenerative Diseases | 2017/10/17 | English | 446 |
| IDH1 and IDH2 Mutations in Gliomas | 2013/03/27 | English | 387 |
| Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives | 2018/04/03 | English | 332 |
| The neurobiology of epilepsy | 2007/07/01 | English | 298 |
| Glutamate and GABA Imbalance Following Traumatic Brain Injury | 2015/03/22 | English | 285 |
| Chemotherapy-Related Cognitive Dysfunction | 2012/03/28 | English | 258 |
| Synapse Pathology in Psychiatric and Neurologic Disease | 2010/03/18 | English | 248 |
| Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene | 2006/02/01 | English | 217 |
| Depression and Parkinson’s Disease: Current Knowledge | 2013/11/05 | English | 212 |
| CNS Demyelination with TNF-α Blockers | 2017/03/21 | English | 211 |
| Neuroinflammation in Neurodegenerative Disorders—a Review | 2017/03/01 | English | 206 |
| Postural Control in Multiple Sclerosis: Implications for Fall Prevention | 2010/06/22 | English | 205 |
| Cognitive Impairment in Huntington Disease: Diagnosis and Treatment | 2011/08/23 | English | 197 |
| Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes | 2014/06/24 | English | 192 |
| Hereditary spastic paraplegia | 2006/02/01 | English | 183 |
| Modern Medical Management of Spinal Cord Injury | 2019/07/30 | English | 174 |
| Cholinergic Dysfunction in Parkinson’s Disease | 2013/08/15 | English | 167 |
| The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential | 2005/08/01 | English | 164 |
| The Pathophysiology of Essential Tremor and Parkinson’s Tremor | 2013/07/27 | English | 162 |
| Adult Primary Intradural Spinal Cord Tumors: A Review | 2011/02/16 | English | 162 |
| Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease | 2004/10/01 | English | 159 |
| Defining Cognitive Reserve and Implications for Cognitive Aging | 2019/01/01 | English | 156 |
| Exercise as Medicine in Multiple Sclerosis—Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives | 2019/11/01 | English | 149 |
| Normal pressure hydrocephalus: Diagnosis and treatment | 2008/09/01 | English | 147 |
| Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) | 2013/02/27 | English | 138 |
| The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders | 2018/09/24 | English | 133 |
| Differential Effects of Non-REM and REM Sleep on Memory Consolidation? | 2014/01/07 | English | 129 |
| Optimal role of temozolomide in the treatment of malignant gliomas | 2005/05/01 | English | 129 |
| Benefits of Exercise Training in Multiple Sclerosis | 2015/07/30 | English | 127 |